NMTC
NEUROONE MEDICAL TECHNOLOGIES CorpCompany Information
- Company Name
- NEUROONE MEDICAL TECHNOLOGIES Corp
- CIK
- CIK0001500198
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NMTC: Nasdaq
- Fiscal Year End
- September 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- NMTC
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-27
- Last sale
- 2026-06-30
- Shares purchased (TTM)
- 1,033,333
- Shares sold (TTM)
- 57,572
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,012,651
- Shares outstanding
- 8,661,624
- Ownership
- 23.24%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -11.48%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2 | 3 | 4 | 7 | 8 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | ||||||
| Accounts Receivable Net Current | 1 | 2 | 3 | 1 | - | 0 | 2 | 0 | 0 | 1 | 1 | - | ||||||
| Inventory Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 2 | ||||||
| Deferred Offering Costs | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | 0 | ||||||
| Assets Current | 6 | 7 | 8 | 10 | 10 | 4 | 6 | 5 | 4 | 5 | 5 | 7 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Assets | 6 | 8 | 9 | 11 | 11 | 4 | 6 | 5 | 5 | 5 | 6 | 8 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | - | - | - | - | ||||||
| Liabilities Current | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | ||||||
| Derivative Liabilities Noncurrent | - | - | - | - | 1 | 1 | 2 | 2 | - | - | - | - | ||||||
| Warrants And Rights Outstanding | 0 | 1 | 1 | 1 | - | - | - | 2 | - | - | - | - | ||||||
| Accrued Liabilities Current | - | - | - | 1 | - | - | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Liabilities | 2 | 2 | 2 | 4 | 3 | 3 | 4 | 5 | 2 | 2 | 1 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 88 | 87 | 86 | 86 | 85 | 77 | 76 | 76 | 75 | 73 | 70 | 69 | ||||||
| Retained Earnings Accumulated Deficit | -84 | -82 | -80 | -79 | -77 | -75 | -73 | -75 | -72 | -69 | -66 | -63 | ||||||
| Stockholders Equity | 4 | 5 | 6 | 7 | 8 | 1 | 3 | 1 | 3 | 4 | 4 | 6 | ||||||
| Liabilities And Stockholders Equity | 6 | 8 | 9 | 11 | 11 | 4 | 6 | 5 | 5 | 5 | 6 | 8 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 9 | 9 | 8 | 8 | 8 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | ||||||
| Shares Outstanding | 9 | 9 | 8 | 8 | 8 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — SEC Financial Statements & Analysis
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) is a surgical & medical instruments & apparatus company, incorporated in DE. NEUROONE MEDICAL TECHNOLOGIES Corp trades on Nasdaq as: NMTC. NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, NEUROONE MEDICAL TECHNOLOGIES Corp carries a market cap of $26.33M, a P/E ratio of -3.54x, a P/B ratio of 6.99x, a P/S ratio of 2.78x, an enterprise value of $24.28M, and an EV/EBITDA multiple of -3.17x. On profitability, it posts a gross margin of 55.65%, an operating margin of -83.43%, a net margin of -78.63%, a Return on Equity (ROE) of -124.66%, a Return on Assets (ROA) of -87.56%, and a Return on Invested Capital (ROIC) of -724.87%. Per share, it reports EPS of $-0.86, diluted EPS of $-0.85, free cash flow per share of $-0.83, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 42.84% year-over-year, net income growth of 39.51% year-over-year, and EPS growth of 30.48% year-over-year. On the balance sheet, it maintains a current ratio of 2.84x, a quick ratio of 1.56x, working capital of $3.75M, a debt-to-equity ratio of 0.64x, a debt ratio of 0.39, free cash flow of $-7.16M (TTM), and net debt of $-2.05M. Figures sourced from SEC EDGAR.
- Market Cap
- $26.33M
- P/E TTM
- -3.54x
- EPS TTM
- $-0.86
- P/B TTM
- 6.99x
- ROE TTM
- -124.66%
- ROA TTM
- -87.56%
- Debt To Equity
- 0.64x
- Free Cash Flow TTM
- $-7.16M
- Net Revenue TTM Growth 1Y
- 42.84%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NEUROONE MEDICAL TECHNOLOGIES Corp in?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does NMTC trade on?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) trades on the Nasdaq.
Where is NEUROONE MEDICAL TECHNOLOGIES Corp incorporated?
NEUROONE MEDICAL TECHNOLOGIES Corp is incorporated in DE.
When was NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s most recent SEC filing?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is NMTC's market cap?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) has a market capitalization of $26.33M as of 2026-06-30.
What is NMTC's EPS (earnings per share)?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s trailing twelve month EPS is $-0.86 as of 2026-06-30.
What is NMTC's ROE (return on equity)?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s trailing twelve month Return on Equity (ROE) is -124.66% as of 2026-06-30.
What is NMTC's ROA (return on assets)?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s trailing twelve month Return on Assets (ROA) is -87.56% as of 2026-06-30.
What is NMTC's ROIC (return on invested capital)?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s trailing twelve month Return on Invested Capital (ROIC) is -724.87% as of 2026-06-30.
What is NMTC's EV/EBITDA?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)'s trailing twelve month EV/EBITDA is -3.17x as of 2026-06-30.